Clinical Trials Directory

Trials / Unknown

UnknownNCT04376359

The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating Stroke

The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
168 (estimated)
Sponsor
Ya Zhang · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate the evidence for the integration of hyperbaric oxygen therapy (HBOT) as part of interdisciplinary stroke rehabilitation.

Detailed description

Pneumonia complicating stroke is very difficult to manage and has a very poor prognosis, leading to a significantly higher risk of death. Oral opportunistic pathogens have been reported to be associated with the incidence of pneumonia among non-stroke immunocompromised subjects. Preliminary studies found that patients with stroke had higher carriage rates of oral opportunistic pathogens than healthy subjects. Therefore, investigators hypothesize that pneumonia complicating stroke is associated with oral opportunistic pathogens, and hyperbaric oxygen therapy may reduce the incidence of pneumonia complicating stroke by increasing the flow of saliva, which can affect the species and relative abundance of oral opportunistic pathogens. In order to prove this, investigators need to (1) firstly conduct a randomized controlled trial to confirm whether hyperbaric oxygen therapy is able to reduce the levels of plaque, and the incidence of pneumonia complicating stroke at clinical level; (2) secondly employ metagenomics analysis to compare oral rinse samples and respiratory samples, and to identify pneumonia-associated "oral opportunistic pathogens group"; (3) finally elucidate how hyperbaric oxygen therapy influences the species and relative abundance of oral opportunistic pathogens. This proposed study will provide evidence for the integration of hyperbaric oxygen therapy as part of interdisciplinary stroke rehabilitation.

Conditions

Interventions

TypeNameDescription
PROCEDUREhyperbaric oxygen therapyHyperbaric oxygen therapy is the patient put in airtight oxygen tank, by increasing the air pressure in the environment (1.5 to 3.0) under atmospheric pressure, to give 100% oxygen, the patient treatment time is approximately 60 minutes to 120 minutes in this way, can achieve the purpose of greatly increase the oxygen partial pressure in the organization, so as to achieve reverse brain edema, reduce lipid peroxidation, inhibiting leukocyte hyperactivity, rebuild the blood brain barrier.

Timeline

Start date
2021-06-01
Primary completion
2021-06-01
Completion
2021-08-01
First posted
2020-05-06
Last updated
2021-01-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04376359. Inclusion in this directory is not an endorsement.